Malignant pertussis in infants: factors associated with mortality in a multicenter cohort study.

Hyperleukocytosis Leukodepletion Malignant pertussis Pediatric intensive care Risk factors of death

Journal

Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873

Informations de publication

Date de publication:
07 May 2021
Historique:
received: 09 10 2020
accepted: 20 04 2021
entrez: 7 5 2021
pubmed: 8 5 2021
medline: 8 5 2021
Statut: epublish

Résumé

Malignant pertussis (MP) affects young infants and is characterized by respiratory distress, perpetual tachycardia and hyperleukocytosis up to 50 G/l, leading to multiple organ failure and death in 75% of cases. Leukodepletion may improve prognosis. A therapeutic strategy based on leukodepletion and extracorporeal life support (ECLS) according to different thresholds of leucocytes has been proposed by Rowlands and colleagues. We aimed at identifying factors associated with death and assess whether the respect of the Rowlands' strategy is associated with survival. We reviewed all MP infants hospitalized in eight French pediatric intensive care units from January 2008 to November 2013. All infants younger than 3 months of age, admitted for respiratory distress with a diagnosis of pertussis and WBC count ≥ 50 G/l were recorded. Evolution of WBC was analyzed and an optimal threshold for WBC growth was obtained using the ROC-curve method. Clinical and biological characteristics of survivors and non-survivors were compared. Therapeutic management (leukodepletion and/or ECLS) was retrospectively assessed for compliance with Rowlands' algorithm (indication and timing of specific treatments). Twenty-three infants were included. Nine of 23 (40%) died: they presented more frequently cardiovascular failure (100% vs 36%, p = 0.003) and pulmonary hypertension (PHT; 100% vs 29%, p = 0.002) than survivors and the median [IQR] WBC growth was significantly faster among them (21.3 [9.7-28] G/l/day vs 5.9 [3.0-6.8] G/l/day, p = 0.007). WBC growth rate > 12 G/l/day and lymphocyte/neutrophil ratio < 1 were significantly associated with death (p = 0.001 and p = 0.003, respectively). Ten infants (43%) underwent leukodepletion, and seven (30%) underwent ECLS. Management following Rowlands' strategy was associated with survival (100% vs 0%; p < 0.001, relative risk of death = 0.18, 95%-CI [0.05-0.64]). A fast leukocyte growth and leukocytosis with neutrophil predominance during acute pertussis infection were associated with death. These findings should prompt clinicians to closely monitor white blood cells in order to early identify infants at risk of fatal outcome during the course of malignant pertussis. Such an early signal in infants at high risk of death would increase feasibility of compliant care to Rowlands' strategy, with the expectation of a better survival.

Sections du résumé

BACKGROUND BACKGROUND
Malignant pertussis (MP) affects young infants and is characterized by respiratory distress, perpetual tachycardia and hyperleukocytosis up to 50 G/l, leading to multiple organ failure and death in 75% of cases. Leukodepletion may improve prognosis. A therapeutic strategy based on leukodepletion and extracorporeal life support (ECLS) according to different thresholds of leucocytes has been proposed by Rowlands and colleagues. We aimed at identifying factors associated with death and assess whether the respect of the Rowlands' strategy is associated with survival.
METHODS METHODS
We reviewed all MP infants hospitalized in eight French pediatric intensive care units from January 2008 to November 2013. All infants younger than 3 months of age, admitted for respiratory distress with a diagnosis of pertussis and WBC count ≥ 50 G/l were recorded. Evolution of WBC was analyzed and an optimal threshold for WBC growth was obtained using the ROC-curve method. Clinical and biological characteristics of survivors and non-survivors were compared. Therapeutic management (leukodepletion and/or ECLS) was retrospectively assessed for compliance with Rowlands' algorithm (indication and timing of specific treatments).
RESULTS RESULTS
Twenty-three infants were included. Nine of 23 (40%) died: they presented more frequently cardiovascular failure (100% vs 36%, p = 0.003) and pulmonary hypertension (PHT; 100% vs 29%, p = 0.002) than survivors and the median [IQR] WBC growth was significantly faster among them (21.3 [9.7-28] G/l/day vs 5.9 [3.0-6.8] G/l/day, p = 0.007). WBC growth rate > 12 G/l/day and lymphocyte/neutrophil ratio < 1 were significantly associated with death (p = 0.001 and p = 0.003, respectively). Ten infants (43%) underwent leukodepletion, and seven (30%) underwent ECLS. Management following Rowlands' strategy was associated with survival (100% vs 0%; p < 0.001, relative risk of death = 0.18, 95%-CI [0.05-0.64]).
CONCLUSIONS CONCLUSIONS
A fast leukocyte growth and leukocytosis with neutrophil predominance during acute pertussis infection were associated with death. These findings should prompt clinicians to closely monitor white blood cells in order to early identify infants at risk of fatal outcome during the course of malignant pertussis. Such an early signal in infants at high risk of death would increase feasibility of compliant care to Rowlands' strategy, with the expectation of a better survival.

Identifiants

pubmed: 33961197
doi: 10.1186/s13613-021-00856-y
pii: 10.1186/s13613-021-00856-y
pmc: PMC8105476
doi:

Types de publication

Journal Article

Langues

eng

Pagination

70

Références

Intensive Care Med. 2000 Oct;26(10):1512-4
pubmed: 11126265
Chest. 2007 Aug;132(2):410-7
pubmed: 17573487
Crit Care Med. 1993 Nov;21(11):1791-4
pubmed: 8222700
Rev Chilena Infectol. 2012 Jun;29(3):290-306
pubmed: 23096468
Pediatrics. 2010 Oct;126(4):e816-27
pubmed: 20819895
Hematology Am Soc Hematol Educ Program. 2012;2012:475-84
pubmed: 23233622
Pediatrics. 2003 Dec;112(6 Pt 1):1274-8
pubmed: 14654596
J Pediatr. 2003 Nov;143(5):576-81
pubmed: 14615725
Medicine (Baltimore). 2017 Dec;96(48):e8823
pubmed: 29310361
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Transfusion. 2014 Jun;54(6):1630-3
pubmed: 24330004
Arch Pediatr. 2001 Sep;8 Suppl 4:705s-711s
pubmed: 11582916
Pediatr Crit Care Med. 2017 Jan;18(1):e42-e47
pubmed: 27811532
Pediatr Infect Dis J. 2013 Jun;32(6):698-9
pubmed: 23407101
Intensive Care Med. 1998 Oct;24(10):1089-92
pubmed: 9840245
J Pediatric Infect Dis Soc. 2013 Mar;2(1):1-6
pubmed: 26619437
Arch Fr Pediatr. 1956;13(8):880-8
pubmed: 13382369
Pediatr Pulmonol. 2009 Oct;44(10):970-80
pubmed: 19725100
Pediatr Crit Care Med. 2018 Mar;19(3):254-261
pubmed: 29319632
Pediatr Crit Care Med. 2005 Jan;6(1):2-8
pubmed: 15636651
Pediatr Crit Care Med. 2007 May;8(3):207-11
pubmed: 17417115
Pediatr Pulmonol. 2003 Oct;36(4):310-5
pubmed: 12950044
Pediatr Infect Dis J. 2003 Jul;22(7):628-34
pubmed: 12867839
Pediatr Crit Care Med. 2013 May;14(4):356-65
pubmed: 23548960
Pediatrics. 2004 Aug;114(2):e264-6
pubmed: 15286267
J Paediatr Child Health. 2017 Mar;53(3):257-262
pubmed: 28058755
Comput Math Methods Med. 2017;2017:3762651
pubmed: 28642804
Clin Infect Dis. 2008 Aug 1;47(3):328-38
pubmed: 18558873

Auteurs

Mathilde Coquaz-Garoudet (M)

Service de Réanimation et Urgences Pédiatriques, Hospices Civils de Lyon, Hôpital Femme Mère Enfant, 59 Boulevard Pinel, 69677, Bron cedex, France.

Dominique Ploin (D)

Service de Réanimation et Urgences Pédiatriques, Hospices Civils de Lyon, Hôpital Femme Mère Enfant, 59 Boulevard Pinel, 69677, Bron cedex, France.
Laboratoire de Virologie et Pathologie Humaine-VirPath Team, Faculté de Médecine RTH Laennec, CNRS, UMR5308, INSERM U1111, Centre International de Recherche en Infectiologie (CIRI), École Normale Supérieure de Lyon, 7-11 rue Guillaume Paradin, 69372, Lyon cedex 08, France.

Robin Pouyau (R)

Service de Réanimation et Urgences Pédiatriques, Hospices Civils de Lyon, Hôpital Femme Mère Enfant, 59 Boulevard Pinel, 69677, Bron cedex, France.

Yoav Hoffmann (Y)

Pediatric Intensive Care Unit, Western Galilee Medical Centre, PO Box 21, 22100, Nahariya, Israel.

Julien-Frederic Baleine (JF)

Département de Pédiatrie Néonatale et Réanimations, Hôpital Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier cedex 5, France.

Benoît Boeuf (B)

Service de Réanimation Pédiatrique, Centre Hospitalier Universitaire Estaing, 1 Place Lucie Aubrac, 63003, Clermont Ferrand cedex 1, France.

Hugues Patural (H)

Service de Réanimation Néonatale et Pédiatrique, Centre Hospitalier Universitaire de Saint-Etienne, Hôpital Nord, Pôle Mère-Enfant, 42055, Saint-Étienne cedex 2, France.

Anne Millet (A)

Service de Médecine Néonatale et Réanimation Pédiatrique, Centre Hospitalier Universitaire de Grenoble, Hôpital Couple Enfant, Boulevard de la Chantourne, 38700, La Tronche, France.

Marc Labenne (M)

Service d' Anesthésie et de Réanimation Pédiatrique, Assistance Publique-Hôpitaux de Marseille, Hôpital de La Timone, 264 Rue Saint-Pierre, 13385, Marseille cedex 5, France.

Renaud Vialet (R)

Service d' Anesthésie et de Réanimation Pédiatrique, Chemin Des Bourrely, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, 13915, Marseille cedex 20, France.

Didier Pinquier (D)

Service de Pédiatrie Néonatale et Réanimation, Centre Hospitalier Universitaire de Rouen, Pôle Femme Mère Enfant, 1 rue de Germont, 76031, Rouen cedex, France.

Marie Cotillon (M)

Service de Pédiatrie Néonatale et Réanimation, Centre Hospitalier Universitaire de Rouen, Pôle Femme Mère Enfant, 1 rue de Germont, 76031, Rouen cedex, France.

Jérôme Rambaud (J)

Service de Réanimation Néonatale Pédiatrique, Hôpital Trousseau, Assistance Publique-Hôpitaux de Paris, 26 Avenue du Dr Arnold Netter, 75571, Paris, France.

Etienne Javouhey (E)

Service de Réanimation et Urgences Pédiatriques, Hospices Civils de Lyon, Hôpital Femme Mère Enfant, 59 Boulevard Pinel, 69677, Bron cedex, France. etienne.javouhey@chu-lyon.fr.
Université Claude Bernard, Lyon 1, 8 Avenue Rockefeller, 69008, Lyon, France. etienne.javouhey@chu-lyon.fr.

Classifications MeSH